Next Article in Journal
Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons
Previous Article in Journal
Endothelial Protease Activated Receptor 1 (PAR1) Signalling Is Required for Lymphocyte Transmigration across Brain Microvascular Endothelial Cells
Previous Article in Special Issue
Seeking and Exploring Efficient Ways to Target Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357

1
Division of General Surgery, Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria
2
Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria
3
Department of Experimental and Translational Pathology, Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria
4
PIZ—Patho im Zentrum GmbH, 3100 St. Poelten, Austria
5
Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, 1090 Vienna, Austria
6
James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA
7
Division of Blood and Bone Marrow Transplantation, Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
8
Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna, 1090 Vienna, Austria
9
Institute of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
10
CBmed Core Lab 2, Medical University of Vienna, 1090 Vienna, Austria
*
Authors to whom correspondence should be addressed.
Cells 2020, 9(12), 2724; https://doi.org/10.3390/cells9122724
Submission received: 19 August 2020 / Accepted: 23 September 2020 / Published: 21 December 2020
(This article belongs to the Special Issue Killing Cancer: Discovery and Selection of New Target Molecules)
The authors wish to make the following change to their paper [1]: The Affiliations section is incorrect in the published paper with regards to the affiliation numbers of the authors. In addition, the e-mail address and phone number of the corresponding author has been updated.
The original version is:
Elisabeth S. Gruber 1, Georg Oberhuber 2,3, Peter Birner 2, Michaela Schlederer 2, Michael Kenn 4, Wolfgang Schreiner 4, Gerd Jomrich 1, Sebastian F. Schoppmann 1, Michael Gnant 1, William Tse 5,6,* and Lukas Kenner 2,7,8,9,*
1 Division of General Surgery, Department of Surgery, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (E.S.G.); [email protected] (G.J.); [email protected] (S.F.S.); [email protected] (M.G.)
2 Department of Experimental and Translational Pathology, Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (G.O.); [email protected] (P.B.); [email protected] (M.S.)
3 PIZ—patho im zentrum GmbH, 3100 St. Poelten, Austria
4 Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, 1090 Vienna, Austria; [email protected] (M.K.); [email protected] (W.S.)
5 James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA
6 Division of Blood and Bone Marrow Transplantation, Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
7 Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna, 1090 Vienna, Austria
8 Institute of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
9 CBmed Core Lab 2, Medical University of Vienna, 1090 Vienna, Austria
* Correspondence: [email protected] (W.T.); [email protected] (L.K.); Tel.: +1-502-562-4363 (W.T.); +43-1-40400-51760 (L.K.)
This should be replaced with:
Elisabeth S. Gruber 1,2, Georg Oberhuber 3,4, Peter Birner 3, Michaela Schlederer 3, Michael Kenn 5, Wolfgang Schreiner 5, Gerd Jomrich 1,2, Sebastian F. Schoppmann 1,2, Michael Gnant 2, William Tse 6,7,* and Lukas Kenner 3,8,9,10,*
1 Division of General Surgery, Department of Surgery, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (E.S.G.); [email protected] (G.J.); [email protected] (S.F.S.)
2 Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria; [email protected]
3 Department of Experimental and Translational Pathology, Institute of Pathology, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (G.O.); [email protected] (P.B.); [email protected] (M.S.)
4 PIZ—Patho im Zentrum GmbH, 3100 St. Poelten, Austria
5 Section of Biosimulation and Bioinformatics, Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS), Medical University of Vienna, 1090 Vienna, Austria; [email protected] (M.K.); [email protected] (W.S.)
6 James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA
7 Division of Blood and Bone Marrow Transplantation, Department of Medicine, University of Louisville School of Medicine, Louisville, KY 40202, USA
8 Christian Doppler Laboratory for Applied Metabolomics (CDL-AM), Medical University of Vienna, 1090 Vienna, Austria; [email protected] (L.K.)
9 Institute of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, 1210 Vienna, Austria
10 CBmed Core Lab 2, Medical University of Vienna, 1090 Vienna, Austria
* Correspondence: [email protected] (W.T.); [email protected] (L.K.); Tel.: +1-216-778-3845 (W.T.); +43-40400-51760 (L.K.)
We apologize for any inconvenience caused to the readers by this mistake. The manuscript will be updated and the original will remain online on the article webpage.

Reference

  1. Gruber, E.S.; Oberhuber, G.; Birner, P.; Schlederer, M.; Kenn, M.; Schreiner, W.; Jomrich, G.; Schoppmann, S.F.; Gnant, M.; Tse, W.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gruber, E.S.; Oberhuber, G.; Birner, P.; Schlederer, M.; Kenn, M.; Schreiner, W.; Jomrich, G.; Schoppmann, S.F.; Gnant, M.; Tse, W.; et al. Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357. Cells 2020, 9, 2724. https://doi.org/10.3390/cells9122724

AMA Style

Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, et al. Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357. Cells. 2020; 9(12):2724. https://doi.org/10.3390/cells9122724

Chicago/Turabian Style

Gruber, Elisabeth S., Georg Oberhuber, Peter Birner, Michaela Schlederer, Michael Kenn, Wolfgang Schreiner, Gerd Jomrich, Sebastian F. Schoppmann, Michael Gnant, William Tse, and et al. 2020. "Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357" Cells 9, no. 12: 2724. https://doi.org/10.3390/cells9122724

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop